Rapamycin in Relapsed Acute Lymphoblastic Leukemia

This study has been completed.
Sponsor:
Collaborators:
Brigham and Women's Hospital
Boston Children’s Hospital
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Lewis B. Silverman, M.D., Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT00874562
First received: April 1, 2009
Last updated: August 1, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2016
  Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)